Literature DB >> 3895887

B-cell changes occur in patients with sickle cell anemia.

M Venkataraman, M P Westerman.   

Abstract

B- and T-lymphocytes were studied in patients with sickle cell anemia. Samples were analyzed during asymptomatic periods and during vasocclusive pain crises to assess a possible relationship to these periods. Assays of B-cell function and quantitation of B- and T-lymphocytes and their subsets were carried out. During crises, six of the eight patients showed a significant decrease in the number of immunoglobulin-producing cells, together with normal or enhanced blastogenic responses. The total number of T-lymphocytes was normal when measured by the monoclonal antibody OKT3 in contrast to the significantly lower level observed in some patients, as determined by the E-rosette technic. There were no significant changes in the percentage of either helper or suppressor T-cells or in the percentage of B-cells. The results show that changes in in vitro B-cell function occur during vasocclusive pain crises in patients with sickle cell anemia. These may be clinically important in these patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3895887     DOI: 10.1093/ajcp/84.2.153

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

1.  Neutrophil chemotaxis in sickle cell anaemia, sickle cell beta zero thalassaemia, and after splenectomy.

Authors:  E A Donadi; R P Falcão
Journal:  J Clin Pathol       Date:  1987-06       Impact factor: 3.411

2.  Splenic morphological changes are accompanied by altered baseline immunity in a mouse model of sickle-cell disease.

Authors:  Steven M Szczepanek; Jeffrey T McNamara; Eric R Secor; Prabitha Natarajan; Linda A Guernsey; Lauren A Miller; Enrique Ballesteros; Evan Jellison; Roger S Thrall; Biree Andemariam
Journal:  Am J Pathol       Date:  2012-09-19       Impact factor: 4.307

3.  Genomic architecture of sickle cell disease in West African children.

Authors:  Jacklyn Quinlan; Youssef Idaghdour; Jean-Philippe Goulet; Elias Gbeha; Thibault de Malliard; Vanessa Bruat; Jean-Christophe Grenier; Selma Gomez; Ambaliou Sanni; Mohamed C Rahimy; Philip Awadalla
Journal:  Front Genet       Date:  2014-02-14       Impact factor: 4.599

4.  Sickle Cell Anemia Patients Display an Intricate Cellular and Serum Biomarker Network Highlighted by TCD4+CD69+ Lymphocytes, IL-17/MIP-1β, IL-12/VEGF, and IL-10/IP-10 Axis.

Authors:  Nadja Pinto Garcia; Alexander Leonardo S Júnior; Geyse Adriana S Soares; Thainá Cristina C Costa; Alicia Patrine C Dos Santos; Allyson Guimarães Costa; Andréa Monteiro Tarragô; Rejane Nina Martins; Flávia do Carmo Leão Pontes; Emerson Garcia de Almeida; Erich Vinícius de Paula; Olindo Assis Martins-Filho; Adriana Malheiro
Journal:  J Immunol Res       Date:  2020-01-08       Impact factor: 4.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.